INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Risk Mitigation For Late-Stage Clinical Assets

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.

• Manufacturing Made More Robust And Customer-Centric

  Discover how regional manufacturing, risk-aware practices, and agile strategies are reshaping supply chains to deliver resilience, transparency, and sustainability in today’s complex global environment.

• Pharmaceutical Supply Chain Management Best Practices

  Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.

• Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies

  The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.

• Windsor Framework: What Is It?

  9/2/2025

  Learn about the Windsor Framework and how it addresses the challenges of medicine supply chains between the UK and the EU, creating stability and certainty in the post-Brexit world.

• Top Safety Considerations In Biopharmaceutical Manufacturing

  4/16/2025

  Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

• Outsourcing To ISO 17025 Accredited Suppliers

  1/28/2025

  Discover the advantages of outsourcing equipment calibration to ISO 17025 accredited suppliers, including cost efficiency and regulatory assurance, in our detailed analysis. Read more to transform your calibration processes.

• Building A Purification Toolkit For An Expanding Variety Of mAb Therapeutics

  5/29/2025

  Explore techniques for optimizing purification toolkits for various monoclonal antibody formats. This session covers resin and buffer selection for efficient downstream process development.

• Fast-Track Innovation, Address CMC Challenges In Expedited Pathways

  1/26/2026

  Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.